Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
While many states have legalized medical and recreational marijuana, marijuana remains an illegal controlled substance under federal law. As we have previously discussed, this has created a conundrum of sorts for employers who want to maintain a drug free workplace. In New York State, the landscape for employers has just gotten more challenging.
A bipartisan bill that would treat hemp-derived CBD products as dietary supplements will be reintroduced in the House by Reps. Kurt Schrader (D-Ore.) and Morgan Griffith (R-Va.). The legislation was first introduced in September 2020 and was cosponsored by 18 Democrats and 11 Republicans. It was referred to the House Energy and Commerce Committee but was never heard. The bill puts hemp-based CBD products into the dietary supplement category, which already has an existing regulatory framework. The bill would make CBD legal for use within 90 days of enactment. The legislation would allow CBD manufacturers to produce hemp-derived ingestibles based on the FDA’s dietary supplement standards. The hope is that putting CBD into a preexisting regulatory category could speed up the process and encourage larger food and beverage corporations to begin producing and selling CBD products. Politico Pro
In response to the introduction of the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, introduced by Representatives Kurt Schrader (D-OR) and Morgan Griffith (R-VA), The Council for Responsible Nutrition (CRN) said the legislation will promote a safer and stronger dietary supplement marketplace. The organization also said it will direct the FDA to provide a legal pathway to market for dietary supplements containing hemp-derived cannabidiol (CBD), while still assuring FDA’s stringent requirements for manufacturing, labeling and marketing of other dietary supplements apply to these ingredients. CRN especially appreciates that the legislation includes CBD along with other hemp-derived cannabinoids for potential inclusion in dietary supplements. Council for Responsible Nutrition
Iowa and New Hampshire are taking steps to regulate cannabidiol (CBD) products, drawing comment and reaction from industry associations. The New Hampshire House of Representatives proposed House Bill 272, a bill which would:
- Allow the sale of products containing hemp-derived CBD;
- Require products containing CBD to be registered annually by the manufacturer; and
- Create a position in the Department of Health and Human Services to perform inspections related to those registered products.
The Council for Responsible Nutrition (CRN) submitted comments urging the state to model its requirements for hemp-derived CBD after federal law. The Natural Product Association (NPA) noted that N.H. is the latest in a line of states to fill a federal regulatory void. When it comes to Iowa’s Senate File 43, CRN recommended deleting the bill’s proposed ‘New Section 126.4 Hemp products and consumable hemp products – retail sales – claims’ and references thereof.” Whole Food Magazine
The European Commission’s (EC) Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG Grow) made two additions to the EU CosIng database: listing cannabidiol naturally derived from Cannabis Sativa L. (hemp) and cannabidiol naturally derived from leaves of Cannabis Sativa L. (hemp) as ingredients for use in cosmetic and personal care products. The first listing cannabidiol – derived from extract or tincture or resin of cannabis cited ingredient functions as: anti-sebum, antioxidant, skin conditioning and skin protecting. The second listing cannabis sativa leaf extract cited skin conditioning and skin conditioning emollient as its functions. Cosmetics Design Europe
A lawsuit against manufacturer CBD Universe will go forward after a New York federal judge said there’s enough evidence to support allegations the company knew it was part of a plan to breach a competitor’s contract. U.S. District Judge J. Paul Oetken rejected CBD Universe’s motion to dismiss the lawsuit filed by manufacturer SLS Brands after finding the suit does enough to allege CBD Universe knew about SLS’ contract when it signed an identical agreement with SLS’ business partners. Law 360 (sub. req.)